CIRS, mold illness and chronic inflammation are contested territory. What the labels mean, why exposure and diagnosis come first, and how to spot overpromising.
By the time someone contacts a clinic with mold, CIRS or Lyme in the subject line, they have usually been somewhere else first. Often several places. The pattern is consistent: symptoms that are genuinely disabling and hard to describe, tests that keep coming back unremarkable, and a growing sense that ordinary medicine has run out of things to offer.
That experience is real, and so is the vacuum it leaves. Contested diagnostic territory attracts the most confident marketing in medicine precisely because certainty is what nobody else has been able to provide. This piece tries to be useful in the opposite direction — by setting out what these labels establish, what they do not, and what has to happen before anyone sells you a protocol.
Damp buildings are not controversial. Visible mold growth and water damage are associated with respiratory symptoms, worse asthma control and allergic disease, and remediating a wet building is straightforward public health. What is contested is the further claim that mycotoxins from indoor mold cause a distinct multi-system chronic illness in people without demonstrable allergy or infection.
CIRS, or Chronic Inflammatory Response Syndrome, is the model built on that claim: biotoxin exposure triggering a persistent innate immune response in susceptible people. It is used by a subset of practitioners and does not appear in the diagnostic frameworks most specialists work from. The panels used to support it have not been validated for that purpose the way routine diagnostics are. That is not a statement about whether patients are unwell. It is a statement about whether the label does the work a diagnosis is supposed to do.
Lyme sits differently again. The infection itself is not in dispute: a tick-borne bacterial illness with established testing and an antibiotic course that works well when it is given early. The dispute concerns symptoms that persist afterwards, described in the literature as post-treatment Lyme disease syndrome. Prolonged intravenous antibiotics are sometimes offered for it, and they carry real risks of their own, including serious line infections.
The presentation across all three is remarkably similar, and that similarity is the whole problem. Fatigue that sleep does not fix. Cognitive difficulty — word-finding, short-term memory, an inability to hold a thread. Diffuse pain, unrefreshing sleep, temperature and heart-rate instability, gut disturbance, sensitivity to light, noise or smell.
Routine inflammatory markers are often normal, or mildly and non-specifically raised. That frustrates everyone, and it is regularly offered as proof that a specialist "missed something" only a particular panel can find. The more useful reading is that this cluster is what chronic systemic inflammation feels like whatever drives it, which is why it also describes anaemia, thyroid disease, sleep apnoea, early autoimmune disease, heart failure, depression and several cancers. The same cluster shows up in the general causes of brain fog.
There is an order to this, and it is not negotiable. It exists because every step below changes the meaning of the step after it.
This is a poorly served group of patients, and poorly served groups attract both serious clinicians and opportunists. The difference is usually visible in the first conversation.
The explanation that accounts for everything is usually the one hiding something.
Once exposure is addressed and the diagnostic work is done, there is a legitimate conversation about supporting recovery — and a short list of honest things to say about it. Molecular hydrogen is understood to act as a selective antioxidant, tempering the most aggressive oxidants while leaving the milder species the body uses for signalling largely alone. Sessions run 20 to 40 minutes, two or three times a week, typically as a four to six week starter course.
Ultra RSF (Regenerative Signaling Factors) is an acellular concentrate of more than 300 proteins and growth factors drawn from all six placental regions, containing no live cells, no DNA and no RNA — it is not a stem-cell therapy, whatever it is called elsewhere. The factors are described as supporting immune balance and barrier integrity, and the treatment page sets out how the material is sourced and processed.
Now the limits. Neither protocol is a detoxification treatment. Neither clears mycotoxins, neither eradicates a bacterial infection, and neither treats mold illness, CIRS or persistent Lyme symptoms, because no protocol has been shown to. If that reads as underwhelming next to what you have been offered elsewhere, that gap is the point. The pillar article on inflammation that fails to resolve covers the same evidentiary gap in more detail.
Chronic Inflammatory Response Syndrome is a proposed model used by some practitioners rather than a diagnosis recognised across mainstream specialty practice. The symptoms attributed to it are real; the disagreement is over whether the label identifies one distinct disease and whether the testing used to support it is reliable.
No. Neither molecular hydrogen nor regenerative signaling factors are detoxification treatments, and neither clears mycotoxins or eradicates an infection. A clinic claiming otherwise is describing something the evidence does not support.
Symptoms persisting after treated Lyme disease are described in the literature as post-treatment Lyme disease syndrome, and management belongs with an infectious disease specialist or your primary physician. Extended antibiotic courses carry real risks and should never be started outside that relationship.
Assessing a building is an environmental question rather than a medical one, and a qualified inspector is the right person to ask. Be cautious of any clinic that sells you both the test and the treatment that follows from it.
No. Our physicians do not issue those diagnoses and do not run the panels associated with them. We review your history and existing results, coordinate with your treating physicians, and say plainly when adjunctive care is not appropriate.
This article is general health information, not medical advice, and does not create a physician–patient relationship. It describes mechanisms reported in the literature rather than guaranteed outcomes; individual response varies. Regen MDs provides you an alternative to your current care, and is complementary to your guideline-based medical care. Ultra RSF (Regenerative Signaling Factors) is not a stem-cell therapy. Talk to a licensed clinician before starting, stopping, or changing any treatment.
Resolution is an active phase of healing, not the absence of one. When it fails to arrive, inflammation idles — and that pattern sits underneath most autoimmune disease.
A consumer-protection checklist for a field that has very little of it — including how we would answer all twelve ourselves.
A symptom, not a disease. What brain fog describes, the six ordinary explanations worth excluding before anything else, and why the order you work through them matters.
Thirty minutes with one of our physicians — no cost, no obligation — to review your history and set out the options honestly.